|
US2851458A
(en)
|
1955-06-08 |
1958-09-09 |
Burroughs Wellcome Co |
Diquaternary compounds and the manufacture thereof
|
|
US4678500A
(en)
|
1984-06-29 |
1987-07-07 |
E. I. Du Pont De Nemours And Company |
Herbicidal 2,6-disubstituted benzylsulfonamides and benzenesulfamates
|
|
US5177075A
(en)
|
1988-08-19 |
1993-01-05 |
Warner-Lambert Company |
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
|
|
US4942163A
(en)
|
1989-03-07 |
1990-07-17 |
E. I. Du Pont De Nemours And Company |
1(2H)-isoquinolinones and 1-isoquinolineamines as cancer chemotherapeutic agents
|
|
WO1999018077A1
(en)
|
1997-10-02 |
1999-04-15 |
Eisai Co., Ltd. |
Fused pyridine derivatives
|
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US20040176361A1
(en)
|
2001-05-23 |
2004-09-09 |
Masakazu Fujio |
Fused heterocyclic compound and medicinal use thereof
|
|
AU2002341693B2
(en)
|
2001-09-21 |
2008-05-29 |
Bristol-Myers Squibb Holdings Ireland Unlimited Company |
Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
AU2003255149A1
(en)
|
2002-07-24 |
2004-02-09 |
Kyorin Pharmaceutical Co., Ltd. |
4-(substituted aryl)-5-hydroxyisoquinolinone derivative
|
|
CN100390164C
(zh)
|
2002-10-01 |
2008-05-28 |
三菱制药株式会社 |
异喹啉化合物及其医药用途
|
|
KR20050065624A
(ko)
|
2002-10-23 |
2005-06-29 |
그렌마크 파머수티칼스 엘티디. |
염증성 및 알레르기 질환의 치료에 유용한 신규한트리사이클릭 화합물, 이의 제조 방법 및 이를 함유하는약제 조성물
|
|
ATE540928T1
(de)
*
|
2002-11-22 |
2012-01-15 |
Mitsubishi Tanabe Pharma Corp |
Isochinolinverbindungen und ihre medizinische verwendung
|
|
WO2004058717A1
(en)
|
2002-12-20 |
2004-07-15 |
X-Ceptor Therapeutics, Inc. |
Isoquinolinone derivatives and their use as therapeutic agents
|
|
ATE422895T1
(de)
|
2003-04-16 |
2009-03-15 |
Bristol Myers Squibb Co |
Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus
|
|
TW200536830A
(en)
*
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
|
WO2005075432A1
(ja)
|
2004-02-06 |
2005-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
１−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用
|
|
WO2005113540A1
(ja)
|
2004-05-20 |
2005-12-01 |
Mitsubishi Pharma Corporation |
イソキノリン化合物及びその医薬用途
|
|
US7846915B2
(en)
|
2004-10-20 |
2010-12-07 |
Resverlogix Corporation |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
CN101437514B
(zh)
|
2004-10-22 |
2012-04-25 |
詹森药业有限公司 |
C-fms激酶抑制剂
|
|
ATE412636T1
(de)
|
2004-12-16 |
2008-11-15 |
Hoffmann La Roche |
Piperazinylpyridinderivate als mittel gegen adipositas
|
|
TWI389897B
(zh)
|
2005-02-22 |
2013-03-21 |
Chugai Pharmaceutical Co Ltd |
1- (2H) -isoquinolinone derivatives
|
|
SI1864976T1
(sl)
|
2005-03-31 |
2012-12-31 |
Astellas Pharma Inc. |
Propan-1,3-dionski derivat ali njegova sol
|
|
WO2007016525A2
(en)
|
2005-07-29 |
2007-02-08 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
CN101316592A
(zh)
|
2005-08-24 |
2008-12-03 |
伊诺泰克制药公司 |
茚并异喹啉酮类似物及其用法
|
|
JP2009539963A
(ja)
*
|
2006-06-15 |
2009-11-19 |
クドス ファーマシューティカルズ リミテッド |
Ｐａｒｐ阻害剤
|
|
CA2662112A1
(en)
|
2006-09-05 |
2008-03-13 |
Kyowa Hakko Kirin Co., Ltd. |
Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators
|
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
PT2118074E
(pt)
|
2007-02-01 |
2014-03-20 |
Resverlogix Corp |
Compostos para a prevenção e tratamento de doenças cardiovasculares
|
|
FR2919286A1
(fr)
|
2007-07-27 |
2009-01-30 |
Sanofi Aventis Sa |
Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique.
|
|
US20090054392A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
WO2009027650A1
(en)
|
2007-08-24 |
2009-03-05 |
The Institute Of Cancer: Royal Cancer Hospital |
Materials and methods for exploiting synthetic lethality in brca-associated cancers
|
|
AU2008324203A1
(en)
|
2007-11-05 |
2009-05-14 |
Novartis Ag |
Methods and compositions for measuring Wnt activation and for treating Wnt-related cancers
|
|
DE102008019838A1
(de)
|
2008-04-19 |
2009-12-10 |
Boehringer Ingelheim International Gmbh |
Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
JP5369173B2
(ja)
|
2008-04-22 |
2013-12-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キノリン若しくはイソキノリン置換ｐ２ｘ７アンタゴニスト
|
|
AR074199A1
(es)
|
2008-11-20 |
2010-12-29 |
Glaxosmithkline Llc |
Compuesto de 6-(4-pirimidinil)-1h-indazol, composiciones farmaceuticas que lo comprenden y su uso para preparar un medicamento util para el tratamiento o disminucion de la gravedad del cancer.
|
|
JP2012519661A
(ja)
|
2009-03-06 |
2012-08-30 |
エフ．ホフマン−ラ ロシュ アーゲー |
抗ウイルス性複素環化合物
|
|
NZ617779A
(en)
|
2009-03-18 |
2015-08-28 |
Resverlogix Corp |
Novel anti-inflammatory agents
|
|
US9757368B2
(en)
|
2009-04-22 |
2017-09-12 |
Resverlogix Corp. |
Anti-inflammatory agents
|
|
TWI499418B
(zh)
*
|
2009-05-21 |
2015-09-11 |
Nerviano Medical Sciences Srl |
異喹啉－１（２ｈ）－酮衍生物
|
|
CN102666540A
(zh)
|
2009-10-13 |
2012-09-12 |
Msd欧斯股份有限公司 |
用于治疗乙酰胆碱受体相关疾病的稠合吖嗪衍生物
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
CN102947274A
(zh)
|
2010-06-17 |
2013-02-27 |
诺瓦提斯公司 |
联苯基取代的1,3-二氢-苯并咪唑-2-亚基胺衍生物
|
|
US9181266B2
(en)
|
2011-07-13 |
2015-11-10 |
Novartis Ag |
2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
|
|
US9227982B2
(en)
|
2011-07-13 |
2016-01-05 |
Novartis Ag |
4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors
|
|
CA2841932A1
(en)
|
2011-07-13 |
2013-01-17 |
Novartis Ag |
4 - piperidinyl compounds for use as tankyrase inhibitors
|
|
EP2788328B1
(en)
*
|
2011-11-25 |
2018-01-31 |
Nerviano Medical Sciences S.r.l. |
3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors
|
|
KR101716012B1
(ko)
|
2011-12-31 |
2017-03-13 |
베이진 엘티디 |
Parp 저해제로서의 융합된 테트라 또는 펜타-사이클릭 다이하이드로다이아제피노카르바졸론
|
|
KR101684039B1
(ko)
|
2011-12-31 |
2016-12-07 |
베이진 엘티디 |
Parp 저해제로서의 융합된 테트라 또는 펜타-사이클릭 피리도프탈라지논
|
|
CN104080773B
(zh)
|
2012-01-28 |
2016-12-28 |
默克专利股份公司 |
氮杂环化合物
|
|
WO2013116182A1
(en)
|
2012-01-31 |
2013-08-08 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds as inhibitors of leukotriene production
|
|
US9339503B2
(en)
|
2012-02-09 |
2016-05-17 |
Merck Patent Gmbh |
Tetrahydro-quinazolinone derivatives as TANK and PARP inhibitors
|
|
EP2822944A1
(en)
|
2012-03-05 |
2015-01-14 |
Amgen, Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
RU2696572C2
(ru)
|
2012-03-07 |
2019-08-05 |
Инститьют Оф Кансер Ресёрч: Ройял Кансер Хоспитал (Зе) |
3-арил-5-замещенные соединения изохинолин-1-она и их терапевтическое применение
|
|
HRP20160908T1
(hr)
|
2012-03-28 |
2016-09-23 |
Merck Patent Gmbh |
Biciklički derivati pirazinona
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
SG11201406997WA
(en)
|
2012-05-04 |
2014-11-27 |
Merck Patent Gmbh |
Pyrrolotriazinone derivatives
|
|
WO2013177349A2
(en)
|
2012-05-25 |
2013-11-28 |
Glaxosmithkline Llc |
Quinazolinediones as tankyrase inhibitors
|
|
BR112014030416A2
(pt)
|
2012-06-07 |
2017-06-27 |
Hoffmann La Roche |
composto, métodos para a inibição da tankyrase 1 e para o tratamento do câncer, utilização de um composto, composição e invenção.
|
|
CA2874546A1
(en)
|
2012-06-07 |
2013-12-12 |
F. Hoffmann-La Roche Ag |
Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
|
|
CA2870062A1
(en)
|
2012-06-20 |
2013-12-27 |
F.Hoffmann-La Roche Ag |
Pyrrolopyrazone inhibitors of tankyrase
|
|
HK1201066A1
(en)
|
2012-06-20 |
2015-08-21 |
霍夫曼-拉罗奇有限公司 |
Pyranopyridone inhibitors of tankyrase
|
|
CN104507912B
(zh)
|
2012-08-08 |
2016-09-28 |
默克专利股份公司 |
(氮杂-)异喹啉酮衍生物
|
|
EP2890696A1
(en)
|
2012-08-29 |
2015-07-08 |
Amgen, Inc. |
Quinazolinone compounds and derivatives thereof
|
|
WO2014045101A1
(en)
|
2012-09-21 |
2014-03-27 |
Cellzome Gmbh |
Tetrazolo quinoxaline derivatives as tankyrase inhibitors
|
|
AR092211A1
(es)
|
2012-09-24 |
2015-04-08 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de hidropirrolopirrol
|
|
MX362855B
(es)
|
2012-09-26 |
2019-02-20 |
Merck Patent Gmbh |
Derivados de quinazolinona como inhidores poli (adp-ribosa) polimerasa (parp).
|
|
WO2014087165A1
(en)
|
2012-12-06 |
2014-06-12 |
University Of Bath |
Tankyrase inhibitors
|